Skip to main content
. 2020 Jun 2;12(6):1450. doi: 10.3390/cancers12061450

Figure 2.

Figure 2

EV-derived miRNA expression (-ΔCq) in pre-surgery, post-surgery, and follow-up samples (Group A) and metastatic disease samples (Group B) of ccRCC patients. (A) hsa-miR-25-3p plasmatic EV-expression; (B) hsa-miR-126-5p plasmatic EV-expression; (C) hsa-miR-200c-3p plasmatic EV-expression; (D) hsa-miR-210-3p plasmatic EV-expression; (E) hsa-miR-301a-3p plasmatic EV-expression; (F) hsa-miR-1246 plasmatic EV-expression; (G) hsa-miR-1293 plasmatic EV-expression; * p < 0.05, ** p < 0.001.